A 16-year-old with a longstanding peanut allergy ate a snack bar he had bought from a health food store. Within minutes, he developed throat tightness, hives, and severe breathing difficulty. At the emergency room, he received two doses of epinephrine. His parents reviewed the bar's ingredient list afterward, looking for any trace of peanut. There was none. The only unfamiliar ingredient was a single word: lupin.
His subsequent allergy testing came back positive for lupin immunoglobulin E (IgE) — the specific antibody associated with immediate allergic reactions. The allergist confirmed cross-reactivity between the lupin proteins and the same peanut allergen components that had sensitized him years earlier.
This case, published in the Annals of Allergy, Asthma & Immunology in 2024, is one of several documented instances of severe lupin-triggered reactions in people with peanut allergies who had no idea lupin was in the product — in part because they had never heard of it, and in part because in the United States, lupin is not listed among the major food allergens that manufacturers must declare.
That gap between what European regulators require and what American consumers can reasonably expect to see on a label is the central issue with lupin. It is a gap that has been growing in significance as lupin flour has quietly spread through the food supply.





